An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC/UICC staging system for well-differentiated thyroid cancer

IJ Nixon, LY Wang, JC Migliacci, A Eskander… - Thyroid, 2016 - liebertpub.com
Background: Age is a critical factor in outcome for patients with well-differentiated thyroid
cancer. Currently, age 45 years is used as a cutoff in staging, although there is increasing …

Defining a valid age cutoff in staging of well-differentiated thyroid cancer

IJ Nixon, D Kuk, V Wreesmann, L Morris… - Annals of surgical …, 2016 - Springer
Background Age 45 years is used as a cutoff in the staging of well-differentiated thyroid
cancer (WDTC) as it represents the median age of most datasets. The aim of this study was …

Optimal cut‐off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?

M Kim, YN Kim, WG Kim, S Park, H Kwon… - Clinical …, 2017 - Wiley Online Library
Objective Age> 45 years is included as a variable in the tumor, node, metastases (TNM)
staging of differentiated thyroid cancer (DTC), but a higher cut‐off value has been suggested …

Survival from differentiated thyroid cancer: what has age got to do with it?

I Ganly, IJ Nixon, LY Wang, FL Palmer, JC Migliacci… - Thyroid, 2015 - liebertpub.com
Background: In most staging systems, 45 years of age is used to differentiate low risk thyroid
cancer from high risk thyroid cancer. However, recent studies have questioned both the …

Analysis of age and disease status as predictors of thyroid cancer-specific mortality using the surveillance, epidemiology, and end results database

RK Orosco, T Hussain, KT Brumund, DK Oh, DC Chang… - Thyroid, 2015 - liebertpub.com
Background: Age at diagnosis is incorporated into all relevant staging systems for
differentiated thyroid carcinoma (DTC). There is growing evidence that a specific age cutoff …

A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the …

HST Cao, LE Johnston, DC Chang, M Bouvet - Surgery, 2012 - Elsevier
BACKGROUND: Differentiated thyroid carcinomas (DTC) are the only tumors for which age
is a determinant of stage in the American Joint Committee on Cancer's (AJCC) staging …

Patient age is an independent risk factor of relapse of differentiated thyroid carcinoma and improves the performance of the American Thyroid Association stratification …

P Trimboli, A Piccardo, A Signore, S Valabrega… - Thyroid, 2020 - liebertpub.com
Background: The 2015 American Thyroid Association (ATA) guidelines proposed a three-
category system for estimating the risk of recurrence of differentiated thyroid carcinoma …

Survival in differentiated thyroid cancer: comparing the AJCC cancer staging seventh and eighth editions

S Tam, M Boonsripitayanon, M Amit, BM Fellman, Y Li… - Thyroid, 2018 - liebertpub.com
Background: The American Joint Committee on Cancer Cancer Staging System for
differentiated thyroid cancer has been recently revised. The purpose of this study was to …

[HTML][HTML] The age factor in survival of a population cohort of well-differentiated thyroid cancer

A Mazurat, A Torroni… - Endocrine …, 2013 - ec.bioscientifica.com
Well-differentiated thyroid carcinoma (WDTC) represents a group of thyroid cancers with
excellent prognosis. Age, a well-recognized risk factor for WDTC, has been consistently …

Exploring the relationship between patient age and cancer-specific survival in papillary thyroid cancer: rethinking current staging systems

MA Adam, S Thomas, T Hyslop, RP Scheri… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Patient age is considered to play a unique prognostic role in papillary thyroid
cancer (PTC), with a distinct staging dichotomization at 45 years of age. This is based on …